Short answer · Medically reviewed summary · Last updated: 2026-05-08
Congenital Insensitivity to Pain with Anhidrosis (CIPA), also known as Hereditary Sensory and Autonomic Neuropathy type IV (HSAN IV), is classified under ICD-10 code G60.89 (Other hereditary and idiopathic neuropathy). In the older ICD-9 coding system, this condition is typically categorized under 356.9 (Unspecified hereditary and idiopathic peripheral neuropathy). What is the clinical classification of CIPA? CIPA is an extremely rare autosomal recessive disorder characterized by the inability to feel pain, temperature, and the inability to sweat (anhidrosis).
Congenital Insensitivity to Pain with Anhidrosis (CIPA), also known as Hereditary Sensory and Autonomic Neuropathy type IV (HSAN IV), is classified under ICD-10 code G60.89 (Other hereditary and idiopathic neuropathy). In the older ICD-9 coding system, this condition is typically categorized under 356.9 (Unspecified hereditary and idiopathic peripheral neuropathy).
CIPA is an extremely rare autosomal recessive disorder characterized by the inability to feel pain, temperature, and the inability to sweat (anhidrosis). Because Congenital Insensitivity to Pain with Anhidrosis affects the peripheral nervous system, these coding designations help clinicians track the neurological and autonomic manifestations of the disease. Managing Congenital Insensitivity to Pain with Anhidrosis requires precise coding for insurance and clinical record-keeping to ensure patients receive multidisciplinary care.
Diagnosis of Congenital Insensitivity to Pain with Anhidrosis is primarily clinical, often triggered by unexplained fevers in infancy or self-mutilation behaviors. Genetic testing is the gold standard for confirmation, specifically looking for mutations in the NTRK1 gene. Key diagnostic features include:
Yes, Congenital Insensitivity to Pain with Anhidrosis is an autosomal recessive condition. This means that for a child to be born with Congenital Insensitivity to Pain with Anhidrosis, both parents must be carriers of a mutation in the NTRK1 gene. Genetic counseling is essential for families to understand the 25% recurrence risk for future pregnancies.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.